M
ore than half of all new HIV type 1 (HIV-1) infections are acquired by women through intravaginal exposure (1) (2) (3) (4) (5) . Even though genital mucosal epithelial cells express low to negligible levels of the receptors for HIV and the mucosal microenvironment is laden with soluble antiviral factors, productive infection of T cells and macrophages does occur at these sites and effectively spreads to distant lymphoid tissues, most rapidly to the gut (6) (7) (8) (9) (10) . Dendritic cells (DCs) in the genital mucosal tissues can capture HIV and migrate to the draining lymph nodes where the virus is transmitted to CD4 ϩ T cells (11, 12) . However, the first host cell type in the mucosal surface to sense HIV infection, trigger immune activation, and promote HIV amplification and spread remains unknown. We and others have previously shown that thymic stromal lymphopoietin (TSLP), an epithelial cell-derived interleukin 7 (IL-7)-like cytokine, is expressed in response to microbial infection or allergen exposure (13, 14) . TSLP potently activates human myeloid DCs (mDCs), which display a remarkable ability to induce homeostatic expansion of naïve CD4 ϩ T cells (13, 14) . These studies suggest that TSLP links the communication between epithelial cells and the DCs of the immune system at a molecular level. We therefore hypothesized that HIV entry at the mucosal tissues stimulates epithelial cells to produce TSLP, which may activate DCs, leading to recruitment and expansion of CD4 ϩ T-cell targets for HIV infection. We obtained evidence for HIV induced human epithelial cells to produce TSLP via the NFB signaling pathway in vitro. In rhesus macaques inoculated with simian immunodeficiency virus (SIV) by the vaginal route, we observed dramatic increases in TSLP expression and SIV replication in the vaginal tissues within the first 2 weeks after virus exposure.
Results

HIV Induces Production of TSLP in Epithelial Cells.
To investigate whether HIV induces TSLP production by epithelial cells, we cultured human cervical epithelial cells (C33A) with HIV for 12-18 h at 37°C and analyzed the cell extracts as well as the culture supernatants for TSLP. Compared with the medium control, the T-cell tropic virus HIV-1 IIIB (X4 strain), macrophage tropic HIV-1 YU2 (R5 strain), and a primary clade D HIV-1 isolate 93ZR001.3 were all able to induce C33A cells to produce high levels of TSLP mRNA as measured by quantitative PCR (Fig. 1A) and by RT-PCR (Fig. 1B) . The TSLP expression was also confirmed at the protein level by ELISA (Fig. 1C ) and Western blot analyses (Fig. 1D ). As described in the literature, TSLP expression at the RNA and protein levels was also observed with poly I:C but not lipopolysaccharide (LPS) (15) . The HIV-induced increase in TSLP expression was observed in several different human epithelial cell lines and primary human keratinocytes, but not in other cell types such as the fibroblasts and T cells (Fig. 1E ). As shown in Fig. 1F , significantly high levels of TSLP expression were observed in the C33A cells cultured with both X4 and R5 strains of HIV-1 (HIV-1 MN and HIV-1 ADA , respectively), that are infectious as well as inactivated by treatment with aldrithiol-2 (AT-2), a reagent shown to covalently modify the essential zinc fingers in the nucleocapsid (NC) protein of HIV-1 thereby arresting the viral life cycle before initiation of reverse transcription (16, 17) . On the other hand, no TSLP expression was observed in cells cultured with HIV-1 that is pseudotyped with Vesicular Stomatitis Virus (VSV) envelope (VSV-HIV). These results demonstrate that exposure to diverse HIV-1 strains, both infectious and noninfectious, can result in efficient induction of TSLP expression in a variety of epithelial cells, including primary human keratinocytes.
Transcriptional Activation of the Human TSLP Promoter by HIV Includes NFB Activation. It has recently been shown that TSLP expression can be induced in airway epithelial cells by proinflammatory mediators (IL-1␤, TNF-␣) and agonists for toll-like receptors 2, 8, and 9 (TLR2, TLR8, and TLR9, respectively), via the induction of NFB, and an NFB-binding site was also identified within the human TSLP (hTSLP) promoter (18) . We investigated whether the mechanism by which HIV induces TSLP expression in epithelial cells involves NFB signaling. Cervical epithelial cells (C33A) were transfected with a luciferase reporter plasmid containing either the full-length hTSLP promoter which contains an NFB-binding site 3.7 kb upstream of the start of transcription (TSLP-luc), or a mutated NFB-binding motif (TSLP⌬B-luc) constructed by site-directed mutagenesis (18) . The transfected cells were then incubated with HIV or IL-1␤, as the positive control reagent, and TSLP mRNA expression and luciferase activity were determined. Compared with the medium control, HIV was able to induce an increase in TSLP mRNA expression (309-fold) and the hTSLP promoter activity (178-fold) to levels similar to those observed after stimulation with IL-1␤ ( Fig. 2 A and B) . On the other hand, no significant TSLP mRNA expression or luciferase activity were observed in C33A cells transfected with the construct containing the mutated NFB-binding site and exposed to HIV or IL-1␤ suggesting that HIV-induced TSLP expression, similar to that of IL-1␤, involves the NFB signaling ( Fig. 2 A and B) . Additionally we constructed retroviral vectors expressing the NF-B superrepressor, IB␣SS/AA, or a control sequence pMIGR1 and transfected C33A cells to derive C33A-IB␣SS/AA and C33A-pMIGR1 cell lines, respectively. Expression of IB␣SS/AA, but not pMIGR1, resulted in the abrogation of TSLP expression in response to HIV as well as IL-1␤ in these cells (Fig. 2C) . Together, these results further support the involvement of the NFB signaling pathway in the transcriptional activation of HIV induced TSLP expression.
TSLP from HIV-Exposed Epithelial Cells Activates Human CD11c ؉ Myeloid Dendritic Cells. TSLP has two key functional effects on human myeloid DCs (mDCs) that include upregulation of costimulatory molecules CD80 and CD86, and induction of thymus and activation regulated chemokine (TARC or CCL17) and macrophage-derived chemokine (MDC or CCL22) secretion (14, 19) . To determine the biological activity of TSLP in the supernatants of HIV exposed epithelial cells, we cultured CD11c ϩ mDCs isolated from human peripheral blood mononuclear cells (PBMCs) with supernatants of epithelial cells incubated with HIV (HIV ϩ Sn), recombinant TSLP (rTSLP) at 100 ng/mL, or culture medium (Fig.  3) . We observed significant upregulation of CD80, CD86, and CD40 expression on mDCs after 24 h of culture with HIV ϩ Sn, similar to that with rTSLP (Fig. 3A) . The ability of HIV ϩ Sn and rTSLP to upregulate activation marker expression could be blocked by neutralizing TSLP antibodies (Fig. 3A) . In addition, rTSLP and HIV ϩ Sn stimulated mDC to produce high levels of chemokines CCL17 and CCL22 at both the mRNA and protein levels ( Fig. 3 B and C and Fig. S1 A and B) . This biological activity of TSLP within the HIV ϩ Sn, along with that of rTSLP could also be blocked by neutralizing TSLP antibodies ( Fig. 3 B and C and Fig. S1 A and B) .
Myeloid DCs Activated by TSLP from HIV-Exposed Epithelial Cells
Induce Naïve CD4 ؉ T-Cell Expansion and HIV Infection. To further delineate the biological activity of the HIV-induced TSLP, mDCs activated by the culture supernatants of HIV-exposed epithelial cells (HIV ϩ Sn/DCs) were co-cultured at a 1:1 ratio for 7 days with autologous, naïve CD4 ϩ T cells. We found that, relative to that of DCs treated either with medium (medium/DCs) or HIV Ϫ Sn (HIV Ϫ Sn/DCs), both rTSLP-treated DCs (rTSLP/DCs) and HIV ϩ Sn/DCs induced a significant expansion of CD4 ϩ T cells by day 7 (Fig. 4A) . Increases in the numbers of CD4 ϩ T cells on day 7, as determined by enumerating the total viable cells using the Trypan-blue dye exclusion method, were 1.8-fold for co-cultures with HIV ϩ Sn/DCs and 3.04-fold for those with rTSLP/DCs. Additionally, significant levels of CD4 ϩ T-cell proliferation were observed in co-cultures with rTSLP/DCs and HIV ϩ Sn/DCs, compared to that with medium/DCs and HIV Ϫ Sn/DCs, respectively, as determined by the [ 3 H]thymidine incorporation and CFSE staining methodologies ( Fig. S2 A and B) . A key feature of TSLP-DC is their ability to trigger the homeostatic proliferation of inflammatory Th2 CD4 ϩ T cells that produce the Th2 cytokines IL-4, IL-5, and IL-13 along with the traditional Th1 cytokine TNF-␣ (19). We observed high level expression of each of these cytokines, but not IL-10 or IFN-␥, in the CD4 ϩ T cells co-cultured with HIV ϩ Sn/DCs, similar to that seen with rTSLP/DCs (Fig. S3) . Addition of HIV to the co-cultures resulted in significant increases in infection, as determined by the analysis of the reverse transcriptase (RT) activity, with HIV ϩ Sn/DCs and rTSLP/DCs when compared to respective control co-cultures of HIV Ϫ Sn/DCs and medium/DCs (Fig. 4C ). These changes amounted to 3.2-and 3.4-fold increases in the levels of infection by day 7 in the co-cultures of T cells with HIV ϩ Sn/DCs and rTSLP/DCs, respectively, compared to that with HIV Ϫ Sn/DCs or medium/DCs. The increases in the numbers as well as HIV infection of naïve autologous CD4 ϩ T cells in co-cultures with DCs activated by rTSLP or the HIV ϩ Sn could be blocked by neutralizing TSLP antibodies (Fig. 4 A and B) . Similar results showing increased infection of co-cultured T cells were observed when HIV-1 YU2 , an R5 strain of HIV-1 was used (Fig. S4) . studies with human epithelial cells also occurs after in vivo infection within the mucosal sites of viral entry in the nonhuman primate model by studying vaginal tissues from rhesus macaques intravaginally inoculated with the simian immunodeficiency virus, SIVmac251. For this, we took advantage of rhesus monkey vaginal tissue samples available from an earlier study where the animals were infected by the vaginal route with SIVmac251 and vaginal samples were obtained after necropsy of animals at various time points post-challenge (20) . Immunohistochemistry analyses demonstrated high levels of TSLP in the vaginal mucosa starting as early as day 1 post-inoculation (post-SIV), relative to that seen before infection ( Fig. 5 A and B and Fig. S5 A-F) . The TSLP expression levels remained high at day 14 as assessed in one animal (Fig. 5C ).
The levels of TSLP expression correlated with a 41-and 99-fold increase in TSLP mRNA expression at days 1 and 14, respectively, compared to that in animals before infection as determined by quantitative real time PCR analyses of the mRNA isolated from the tissue samples (Fig. S6 ). This increase in TSLP expression coincided with a large increase in viral RNA positive cells by day 14 post-SIV, relative to day 1 and 0 (uninfected) in these tissues as determined by in situ hybridization (ISH) analyses (Fig. 5 D-F) . Viral RNA copy analyses reported previously for these monkeys was below the detectable level in uninfected animals while post-SIV infection the levels ranged between 4 ϫ 10 2 and 3.6 ϫ 10 4 for day 1 and between 5.0 ϫ 10 5 and 6.0 ϫ 10 5 for days 9 through 14 (20) . Thus, there was a rapid and sustained increase in TSLP expression coinciding with SIV infection in the vaginal mucosa of rhesus macaques after SIV inoculation by the vaginal route. While expression of a number of inflammatory mediators, cytokines and antiviral effector molecules within the vaginal tissues has been reported after vaginal SIV inoculation (21), our in vitro studies showed HIV-induced TSLP induces DC activation, because neutralization of TSLP within the HIV-exposed epithelial cell culture supernatants abrogated DC activation as well as homeostatic expansion and HIV replication of CD4 ϩ T cells in co-cultures. Together, our in vitro data from HIV-exposed human epithelial cells and the results from vaginal tissues in the non-human primates exposed to SIV by the vaginal route suggest that HIV/SIV can effectively manipulate the mucosal microenviroment to ensure local infection by inducing epithelial cells to produce TSLP.
Discussion
In this study, we demonstrate that diverse HIV-1 strains, either live or inactivated, induce TSLP production by human epithelial cells, including primary human keratinocytes, in culture. TSLP released by epithelial cells in response to HIV strongly activates human myeloid DC, which potently induced a robust homeostatic proliferation of CD4 ϩ T cells and promoted HIV replication in these activated T cells. These data suggest that epithelial cells represent the first target for HIV to trigger DC-mediated immune activation that facilitates viral replication in CD4 ϩ T cells during early vaginal HIV infection. This hypothesis is further supported by data from the in vivo experiments showing that inoculation of SIV into the vaginal tract of rhesus monkeys induced rapid upregulation of TSLP in epithelial cells that coincided with high levels of infected cells in situ.
Literature reports suggest that genital epithelial cells cannot be infected by HIV and may only permit transcytosis through epithelial cell surface proteins enabling infection of the nearby DCs and CD4 ϩ T cells (22) (23) (24) (25) (26) . In our studies we observed induction of TSLP expression by both live and inactivated HIV-1 strains. It has been reported that certain microbial products that mimic doublestranded RNA, such as poly I:C, induce TSLP production by interacting with toll-like receptors (TLR), specifically TLR3, on the epithelial cells (15) . In fact, in our studies we did observe TSLP production by the different epithelial cells used in response to stimulation with poly I:C, however, we believe the capacity of HIV to induce TSLP as demonstrated in our studies is independent of TLR3 interaction because the infection process of HIV does not involve a double-stranded RNA step and AT2-treated HIV-1 strains incapable of viral replication were effective in inducing TSLP production in the epithelial cells. It is possible that HIV may induce TSLP expression through TLR7 or TLR8 interactions since both receptors are known to recognize single-stranded RNA within the cellular compartment and both upregulate the NFB signaling pathway which we have shown is involved in HIV induced TSLP expression, similar to that reported after stimulation with certain inflammatory cytokines and TLR ligands (18) .
Studies of SIV infection in the vaginal tissues of rhesus macaques showed only a few SIV-infected cells between days 1-4 postinfection, but substantial increase beyond day 4 with a concurrent increase at the distant lymphoid tissues (20) . Thus, the outcome of HIV exposure at the vaginal mucosa, which exhibits low pH and contains several antiviral soluble factors, is dependent on the extent to which the virus can manipulate the mucosal tissue microenvironment within the first few days to ensure virus dissemination locally. Results from the present investigation suggest that induction of TSLP production by the mucosal epithelial cells may be a strategy adopted by HIV to successfully maneuver the hostile vaginal mucosal microenvironment through DC-mediated recruitment of CD4 ϩ T-cell targets.
It has been shown that antiviral CD8 T-cell responses were generated within the vaginal mucosal tissues of rhesus macaques infected by the vaginal route, but at a slower rate and to a much lower level compared to the peak viral loads and this trend was even more pronounced in the gut (27) . Based on these observations, it has been suggested that the antiviral immunity at the vaginal mucosa, as measured by analyzing for CD8 T-cell response is ''too little and too late'' to provide protection in terms of clearance of infection and prevention of CD4 ϩ T-cell loss. However, it has not been clear what changes within the mucosal microenvironment subsequent to viral exposure facilitate kinetics of virus infection over that of antiviral host immune responses. In this study we observed that virus-induced TSLP expression paralleled SIV infection within the vaginal tissues over the first 2 weeks postinfection. These data, together with the results from in vitro studies support virus-induced TSLP production by the mucosal epithelial cells as a critical event for DC-mediated expansion of HIV infected CD4 ϩ T cells during vaginal HIV transmission.
Historically, the role of TSLP has been documented in the study of allergic diseases, but here we show that TSLP may be an important player in the acute phase of HIV-1 infection by creating an environment that is conducive for sustaining the small dose of the initial virus inoculum that crosses the mucosal barrier. This raises the possibility of targeting TSLP as a strategy against mucosal HIV-1 transmission and/or TSLP as a potential modulator of antigen-specific immune responses induced by candidate vaccines delivered at these mucosal viral entry sites. DC Activation and Viability. The CD11c ϩ myeloid DCs cultured with medium, rTSLP, HIV Ϫ Sn, or HIV ϩ Sn for 24 h were collected and resuspended in EDTAcontaining medium. Viability of the DCs was determined by the standard Trypan blue dye-exclusion method. To determine the activation status, the DCs were stained with PE-conjugated mouse anti-human mAbs to CD40, CD80 and CD86 and an IgG1 isotype control (all from BD Biosciences) and analyzed on an LSR II flow cytometer (BD Biosciences) using flowjo software (version 8.3.4, Tree Star). The dead cells were excluded from the analyses by using the violet Live/Dead stain kit (Invitrogen). The DC culture supernatants were collected at 24 h, frozen at Ϫ80°C, and analyzed within 3 months with protein ELISA kits for TARC and MDC (R&D Systems). In some experiments, RNA samples prepared from the cultured mDCs were used for gene expression analyses.
Materials and Methods
Cell
mDC-CD4 ؉ T-Cell Co-Cultures. Activated mDC were co-cultured with 2.5 to 5.0 ϫ 10 4 purified autologous naïve CD4 ϩ T cells (DC:T cell ratio, 1:1; SI Materials and Methods) in a round bottomed 96-well culture plates for 7 days. In some experiments, HIV-1 IIIB was added to the co-cultures overnight, and the cells were washed three times to remove any free viral particles. The co-cultures were resuspended in RPMI medium containing 10% FBS. The mixture was then incubated for 5 min in 37°C in 10% FBS-RPMI 1640 and the cells were pelleted by centrifugation. The cells were subsequently washed three times with 10% FBS-RPMI 1640. On days 4 and 7, the viable cell counts were determined by the standard Trypan blue dye-exclusion method. In the co-cultures where HIV is added, the relative levels of infection were determined by assaying for reverse transcriptase (RT) activity in the culture supernatants.
In Situ Hybridization for Detection of SIV RNA-Positive Cells. The in situ hybridization analysis (ISH) was performed on the vaginal tissue sections using 35 S-labeled SIV riboprobes as described earlier (29), with modifications. Radioactive probes had a specific activity of Ͼ3.5 ϫ 10 8 cpm/g as determined by the in vitro transcription labeling of the SIV gag and env genes. The hybridization solution contained radiolabeled SIV probes at a total concentration of 1.5 ϫ 10 6 cpm/100 L. The riboprobe mixture in the hybridization buffer was layered over each tissue section. The slides were coated with LM-1 autoradiographic emulsion (Amersham) and allowed to develop at 4°C for 14 days. Controls for ISH included: (i) matched tissues from SIV-uninfected rhesus monkeys, (ii) tissues from SIVinfected rhesus monkeys with high virus loads (positive control), (iii) serial tissue sections hybridized with SIV sense riboprobes, and (iv) omission of the probe in the hybridization mixture. were used for immunohistochemical staining for TSLP showed low levels of TSLP in the normal vaginal tissues, but higher levels after 1 and 14 days post-SIV exposure. The sequential samples were also subjected to in situ hybridization (ISH) analyses using radiolabeled riboprobes, and low numbers of SIV RNA ϩ cells were observed at day 1 and much increased numbers at day 14 postinfection (shown with black arrows in E and F), relative to tissue from an uninfected monkey (D).
SIV RNA Measurement. Tissue RNA samples were analyzed for viral RNA (vRNA) by a quantitative branched DNA (bDNA) assay (30) and reported as viral RNA copy numbers per microgram total tissue RNA. The detection limit of this assay is 125 copies of vRNA. To evaluate the specificity of the tissue assay, samples were collected from three animals that had not been exposed to SIV (21) . Excluding one spurious result, average values for the bDNA assay were 113 copies/g tissues RNA in the uninfected animals. Thus, we set the cut-off for the assay at 200 copies/g tissue RNA, the average ϩ 2 standard deviation (SD) values. Tissue sample with less than 200 copies of vRNA/g total tissue RNA were reported as negative.
Immunohistochemistry. The vaginal tissue sections were incubated with either rat anti-human TSLP (mAb 12F3, DNAX), mouse anti-human CD4 (mAb M-T477, BD PharMingen) or mouse anti-human CD11c (mAb AHS1153, Biosource) at room temperature for 1 h in PBS. The slides were washed with PBS twice and incubated with biotinylated secondary antibody for 30 min (PK-4004, Vector Laboratories) before washing and treatment with avidin-peroxidase complex reagents for 30 min (PK-4004, Vector Laboratories). Subsequently, the slides were washed and incubated with the substrate SK-4200, which stained red, or SK-4100, which stained brown (Vector Laboratories).
Real-Time Quantitative RT-PCR. Epithelial cells exposed to different HIV-1 strains or mDC subjected various treatments were lysed and mRNA was extracted with an RNeasy kit (Qiagen). Reverse transcription was done with SuperScript II (Invitrogen), and the cDNA samples were analyzed by real-time quantitative PCR assay with an ABI Prism 7500 Sequence Detection system (Applied Biosystems). Reactions were incubated for 2 min at 50°C, denatured for 10 min at 95°C, and subjected to 40 two-step amplification cycles with annealing-extension for 60°C for 1 min followed by denaturation at 95°C for 15 s. For the analysis of human TSLP and human GAPDH real time PCR probes were purchased directly from the manufacturer (SuperArray). For the analysis of human TARC and MDC, the primer sequences were as follows: TARC: 5Ј-CATGGCCCCACTGAAGATG-3Ј and 5Ј-CCTGGAGCAGTCCTCAGATGTC-3Ј and MDC: 5Ј-GCATGGCTCGCCTACAGACT-3Ј and 5Ј-CAGACGGTAACGGACGTAATCA-3Ј.
ELISA.
Concentrations of the TSLP protein in cell-free supernatants and cell lysates were measured using a specific ELISA kit (R&D Systems). The minimal detection limit for this kit is set to 31.25 pg/mL.
Western Blot Analysis. Aliquots of 2 ϫ 10 7 epithelial cells exposed to HIV were subjected to lysis in 2ϫ Laemmli buffer. The lysates were then mixed with 4ϫ loading buffer and resolved on a 17.5% SDS polyacrylamide gel followed by Western blot analyses using rat anti-TSLP (mAb 12F3, DNAX) at a dilution of 1:1,000 as the primary antibody and horseradish peroxidase labeled donkey anti-rat IgG H&L secondary antibody (diluted 1:10,000) and the femto fluorometric system (Pierce Biotechnology).
Transfection and Luciferase Assay. Cervical epithelial cells (3 ϫ 10 5 ) were transfected, using the calcium phosphate method, with 1 g luciferase reporter plasmid driven by wild-type or mutated TSLP promoter and 15 ng control renilla luciferase reporter driven by a constitutive thymidine kinase promoter (pRL-tkluc) (Promega). The TSLP promoter plasmids were obtained from Steven F. Ziegler at the University Of Washington School Of Medicine. The cells were cultured for 48 h and then exposed to IL-1␤ and HIV overnight. Cells were harvested and lysed in 100 L lysis buffer. Luciferase activity was measured using a Lumat LB9507 luminometer to determine whether HIV exposure of epithelial cells resulted in an induction of luciferase expression as robust as that previously seen with IL-1␤. Relative luciferase activity was calculated as a ratio of relative light units to relative renilla luciferase units. In each experiment, samples were analyzed in triplicate and each experiment was repeated at least three times.
Generation of C33A Cells Expressing an NF-B Superrepressor. An IkBa mutant harboring mutations in its phosphorylation sites, serines 32 and 36 (named IkBaSS/AA), was cloned into the retroviral vector pMIGR1 (provided by Warren Pear, Abramson Family Cancer Research Institute). Since the IkBaSS/AA is resistant to inducible degradation (32) , it functions as a superrepressor of NF-B. To produce recombinant retroviruses, pMIGR1-IkBaSS/AA or pMIGR1 vector control was transiently transfected into 293 cells along with the packaging plasmid pCL-Ampho and the VSV-G plasmid, as previously described (33) . The recombinant viruses were used to infect C33A cells, which were used as the bulk of cells in the experiments.
Statistical Analyses. Using the Student t test the P values were calculated to determine the significance of fold increase in CD4 ϩ T cells and HIV infection (RT activity).
